Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
26,500
+1,050 (4.13%)
May 13, 2025, 3:30 PM KST
-8.46%
Market Cap 1.01T
Revenue (ttm) 34.01B
Net Income (ttm) 876.53M
Shares Out 38.25M
EPS (ttm) 22.92
PE Ratio 1,156.36
Forward PE 76.15
Dividend n/a
Ex-Dividend Date n/a
Volume 108,923
Average Volume 187,192
Open 25,550
Previous Close 25,450
Day's Range 25,550 - 26,850
52-Week Range 21,600 - 45,850
Beta 1.62
RSI 39.63
Earnings Date May 13, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 51
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.